Publicaciones en las que colabora con PABLO AVANZAS FERNANDEZ (21)

2023

  1. Chromosome Y Haplogroup R Was Associated with the Risk of Premature Myocardial Infarction with ST-Elevation: Data from the CholeSTEMI Registry

    Journal of Clinical Medicine, Vol. 12, Núm. 14

  2. Clinical Evaluation of Patients with Genetically Confirmed Familial Hypercholesterolemia

    Journal of Clinical Medicine, Vol. 12, Núm. 3

  3. Mitochondrial Heteroplasmy as a Marker for Premature Coronary Artery Disease: Analysis of the Poly-C Tract of the Control Region Sequence

    Journal of Clinical Medicine, Vol. 12, Núm. 6

  4. Opportunistic Genetic Screening for Familial Hypercholesterolemia in Heart Transplant Patients

    Journal of Clinical Medicine, Vol. 12, Núm. 3

2022

  1. Different Phenotypes in Monozygotic Twins, Carriers of the Same Pathogenic Variant for Hypertrophic Cardiomyopathy

    Life, Vol. 12, Núm. 9

2021

  1. The APOB polymorphism rs1801701 A/G (p.R3638Q) is an independent risk factor for early-onset coronary artery disease: Data from a Spanish cohort

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 31, Núm. 5, pp. 1564-1568

  2. The renin–angiotensin–aldosterone system and coronavirus disease 2019

    European Cardiology Review , Vol. 16

2020

  1. Characterization of left ventricular non-compaction cardiomyopathy

    Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-16

  2. Clinical implications and gender differences of kcnq1 p.Gly168arg pathogenic variant in long qt syndrome

    Journal of Clinical Medicine, Vol. 9, Núm. 12, pp. 1-12

  3. Familial hypercholesterolemia in premature acute coronary syndrome. Insights from cholestemi registry

    Journal of Clinical Medicine, Vol. 9, Núm. 11, pp. 1-12

  4. IL17RA in early-onset coronary artery disease: Total leukocyte transcript analysis and promoter polymorphism (rs4819554) association

    Cytokine, Vol. 136

2019

  1. Gene variants in the NF-KB pathway (NFKB1, NFKBIA, NFKBIZ) and risk for early-onset coronary artery disease

    Immunology Letters, Vol. 208, pp. 39-43

  2. Spectral analysis of the QT interval increases the prediction accuracy of clinical variables in Brugada syndrome

    Journal of Clinical Medicine, Vol. 8, Núm. 10

2018

  1. Genetic variation at the long noncoding RNA H19 gene is associated with the risk of hypertrophic cardiomyopathy

    Epigenomics, Vol. 10, Núm. 7, pp. 865-873

  2. Role of syncope in predicting adverse outcomes in patients with suspected Brugada syndrome undergoing standardized flecainide testing

    Europace, Vol. 20, Núm. FI1, pp. f64-f71

2017

  1. Screening of the Filamin C Gene in a Large Cohort of Hypertrophic Cardiomyopathy Patients

    Circulation: Cardiovascular Genetics, Vol. 10, Núm. 2

2016

  1. Surveillance after cardiac arrest in patients with Brugada syndrome without an implantable defibrillator: An alarm effect of the previous syncope

    International Journal of Cardiology, Vol. 218, pp. 69-74

2015

  1. Time-dependent responses to provocative testing with flecainide in the diagnosis of Brugada syndrome

    Heart Rhythm, Vol. 12, Núm. 2, pp. 350-357

2011

  1. Mitochondrial DNA and TFAM gene variation in early-onset myocardial infarction: Evidence for an association to haplogroup H

    Mitochondrion, Vol. 11, Núm. 1, pp. 176-181

2009

  1. Lack of association between endothelin-1 gene variants and myocardial infarction

    Journal of Atherosclerosis and Thrombosis, Vol. 16, Núm. 4, pp. 388-395